Free tool
Mid cap stocks
We cover 25 companies in the mid cap size band. The median market value in the group is $3.34B. Across the group, the median move over the past trading day is +0.62%. 58% of the 24 with a 200-day average trade above it. Price change over the past year runs from −22.2% to +48.1% across the middle 80 percent of the group, with a median of +0.7%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
Table
25 of 2,729 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| KRK.WA | Krka, d. d. | $9.20B | Mid cap | +30.59% | Nov 12, 2026 |
| QIA.DE | Qiagen N.V. | $8.99B | Mid cap | −6.73% | Nov 4, 2026 |
| ALK-B.CO | ALK-Abelló A/S | $7.26B | Mid cap | +5.09% | Nov 17, 2026 |
| GETI-B.ST | Getinge AB (publ) | $7.01B | Mid cap | +20.89% | Oct 21, 2026 |
| HLUN-B.CO | H. Lundbeck A/S | $6.47B | Mid cap | +8.99% | Nov 11, 2026 |
| HLUN-A.CO | H. Lundbeck A/S | $6.40B | Mid cap | +29.71% | Nov 11, 2026 |
| SECT-B.ST | Sectra AB (publ) | $5.63B | Mid cap | −17.02% | Sep 4, 2026 |
| OBCK.DE | Ottobock SE & Co. KGaA | $4.40B | Mid cap | +0.68% | Nov 12, 2026 |
| BBZA.DE | BB Biotech AG | $3.87B | Mid cap | +7.22% | Oct 23, 2026 |
| MCOV-B.ST | Medicover AB (publ) | $3.85B | Mid cap | −8.20% | Nov 4, 2026 |
| CAMX.ST | Camurus AB (publ) | $3.79B | Mid cap | −15.35% | Nov 5, 2026 |
| 22Z.DE | Zealand Pharma A/S | $3.37B | Mid cap | −28.16% | Nov 12, 2026 |
| ZEAL.CO | Zealand Pharma A/S | $3.34B | Mid cap | −25.94% | Nov 12, 2026 |
| VIRP.PA | Virbac SA | $3.24B | Mid cap | −2.08% | Sep 17, 2026 |
| ASKER.ST | Asker Healthcare Group AB (publ) | $2.99B | Mid cap | −24.65% | Nov 4, 2026 |
| B72.DE | AtaiBeckley Inc. | $2.79B | Mid cap | +59.69% | Nov 12, 2026 |
| BV3.DE | Bavarian Nordic A/S | $2.55B | Mid cap | +15.65% | Nov 13, 2026 |
| EMEIS.PA | emeis Société anonyme | $2.55B | Mid cap | +10.93% | Sep 23, 2026 |
| BAVA.CO | Bavarian Nordic A/S | $2.51B | Mid cap | −7.97% | Nov 13, 2026 |
| DRW3.DE | Drägerwerk AG & Co. KGaA | $2.45B | Mid cap | +70.53% | Oct 29, 2026 |
| DMP.DE | Dermapharm Holding SE | $2.31B | Mid cap | +27.27% | Nov 12, 2026 |
| GN.CO | GN Store Nord A/S | $2.13B | Mid cap | −18.50% | Nov 5, 2026 |
| ALIF-B.ST | AddLife AB (publ) | $2.08B | Mid cap | −7.20% | Oct 21, 2026 |
| GNS.L | Genus plc | $2.08B | Mid cap | −12.94% | Sep 10, 2026 |
| NANO.PA | Nanobiotix S.A. | $2.05B | Mid cap | +358.21% | Sep 29, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.